| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 8459412 | Radiotherapy and Oncology | 2017 | 8 Pages |
Abstract
Spatiotemporal fractionation may reduce the risk of liver toxicity or facilitate dose escalation in liver SBRT in circumstances where the mean dose to the non-involved liver is the prescription-limiting factor.
Related Topics
Life Sciences
Biochemistry, Genetics and Molecular Biology
Cancer Research
Authors
Jan Unkelbach, Dávid Papp, Melissa R. Gaddy, Nicolaus Andratschke, Theodore Hong, Matthias Guckenberger,